{"id":"CHEMBL1000","canonicalSmiles":"O=C(O)COCCN1CCN(C(c2ccccc2)c2ccc(Cl)cc2)CC1","inchiKey":"ZKLPARSLTMPFCP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETIRIZINE","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AC-170","Cetirizine"],"crossReferences":{"DailyMed":["cetirizine%20hydrochloride"],"PubChem":["174007233","90341832"],"Wikipedia":["Cetirizine"],"drugbank":["DB00341"],"chEBI":["3561"]},"childChemblIds":["CHEMBL1201113","CHEMBL1607273"],"count":13,"approvedIndications":["EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["EFO_0005854","EFO_0008521","HP_0000989","HP_0000964","EFO_0003821","EFO_0003929","EFO_0000274","EFO_0003885","EFO_0005531","EFO_0009444","MONDO_0002406","EFO_0004256","EFO_0007141","EFO_0003830","EFO_1001417","EFO_1000749","EFO_0004191","EFO_0003785","EFO_0003956"],"count":19},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1995 and is indicated for allergy and has 12 investigational indications."}
{"id":"CHEMBL1040","canonicalSmiles":"C=C1CC[C@H](O)C/C1=C/C=C1\\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)(C)O","inchiKey":"JWUBBDSIWDLEOM-DTOXIADCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIFEDIOL","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Calcifediol"],"crossReferences":{"DailyMed":["calcifediol"],"PubChem":["144205540","26754888","50110817"],"drugbank":["DB00146"],"chEBI":["17933"]},"childChemblIds":["CHEMBL3544909","CHEMBL4594399"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_1001173","MONDO_0100096","HP_0002024","HP_0001919","EFO_0000270","EFO_0003762","EFO_0000612","EFO_0003918"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980."}
{"id":"CHEMBL107498","canonicalSmiles":"CCCCCCCCCC(=O)O","inchiKey":"GHVNFZFCNZKVNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECANOIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Decanoic Acid","Decanoic Acid Anion"],"crossReferences":{"PubChem":["144207082","144209407","144210684","17389668","26752972","85272325"],"Wikipedia":["Decanoic_acid"],"drugbank":["DB03600"],"chEBI":["30813"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1082508","canonicalSmiles":"NC(=O)NC[C@@H]1CCCc2cc(S(=O)(=O)c3cccc(F)c3)ccc21","inchiKey":"MTTHRRVVGMPYQG-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LANDIPIRDINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Landipirdine","R0-5025181","R0-5025181-000","R05025181","R05025181-000","RO5025181","RO5025181-000","SYN-120","SYN120"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1084102","canonicalSmiles":"O=C(O)CC[C@@H](Cc1ccc(OCc2ccccc2)cc1)NC(=O)CCCCCCc1ccccc1","inchiKey":"KWLUIYFCMHKLKY-NDEPHWFRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1084102","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04287"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1084625","canonicalSmiles":"Cc1cc2c(s1)c1cnn(Cc3ccccc3F)c(=O)c1n2C","inchiKey":"IEWYEWDDQWYJLU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1084625","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["57646207","57646208","851783"],"drugbank":["DB07628"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL108545","canonicalSmiles":"COC(=O)c1ccccc1O","inchiKey":"OSWPMRLSEDHDFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL SALICYLATE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aspellin","Balmosa","Bengue's balsam","Deep heat","Dubam","Gppe lin","Gppe rub","Luma","Methyl Salicylate","Nasciodine","P.r.","Radian-b","Rhodiaflor","Sloans","Thera-gesic"],"synonyms":["Betula oil","Birch oil, sweet","FEMA NO. 2745","Gaultheria oil","Methyl salicylate","NSC-8204","Sweet birch oil","Teaberry oil","Wintergreen oil"],"crossReferences":{"PubChem":["144204632","144208741","144210457","17388914","26752907"],"Wikipedia":["Methyl_salicylate"],"drugbank":["DB09543"],"chEBI":["31832"]},"count":5,"approvedIndications":["HP_0003326","EFO_0005856","EFO_0003843","EFO_1001434","EFO_1000941"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 5 approved indications."}
{"id":"CHEMBL1097205","canonicalSmiles":"CC1(C)C2CCC1(C)C(O)C2","inchiKey":"DTGKSKDOIYIVQL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-BORNEOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(+/-)-Borneol","(+/-)-Isoborneol"],"crossReferences":{"drugbank":["DB11288"],"chEBI":["28093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1146","canonicalSmiles":"Cn1nnnc1SCC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](O)c3ccccc3)[C@H]2SC1","inchiKey":"OLVCFLKTBJRLHI-AXAPSJFSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFAMANDOLE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["COMPOUND 83405","COMPOUND-83405","Cefamandole","Cephamandole","J01DC03"],"crossReferences":{"Wikipedia":["Cefamandole"],"drugbank":["DB01326"],"chEBI":["3480"]},"childChemblIds":["CHEMBL3230485","CHEMBL1360024"],"count":2,"approvedIndications":["EFO_0000771"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 1 investigational indication."}
{"id":"CHEMBL1161949","canonicalSmiles":"CCCCCCCOc1cccc(C(=O)O)c1","inchiKey":"FOFZVIUYGPBWLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-(Heptyloxy)Benzoate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-(Heptyloxy)Benzoate","3-(Heptyloxy)Benzoic Acid"],"crossReferences":{"drugbank":["DB07355"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1170","canonicalSmiles":"CCC(=O)O[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C","inchiKey":"PDMMFKSKQVNJMI-BLQWBTBKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESTOSTERONE PROPIONATE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Testosterone propionate"],"synonyms":["NRB-03689","NSC-9166","Testosterone Propionate","Testosterone propionate","Testosterone propionate ciii"],"crossReferences":{"PubChem":["11112138","144203881","144212587","170464835","56463044"],"drugbank":["DB01420"],"chEBI":["9466"]},"count":1,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_1001271"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1974 and has 1 investigational indication."}
{"id":"CHEMBL1172736","canonicalSmiles":"N=C(N)NCCCCCCC(=O)N[C@@H](O)C(=O)NCCCCNCCCN","inchiKey":"IDINUJSAMVOPCM-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1172736","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Gusperimus"],"drugbank":["DB12991"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1178595","canonicalSmiles":"CC[C@H](N)Cc1ccccc1","inchiKey":"IOLQWLOHKZENDW-JTQLQIEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1178595","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02972"]},"childChemblIds":["CHEMBL33843"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200367","canonicalSmiles":"CCOP(=O)(OCC)SCC[N+](C)(C)C.[I-]","inchiKey":"OVXQHPWHMXOFRD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ECHOTHIOPHATE IODIDE","yearOfFirstApproval":1960,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201341","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Phospholine iodide"],"synonyms":["217-MI","Echothiophate iodide","Ecostigmine iodide","Ecothiopate iodide"],"crossReferences":{"chEBI":["59849"]},"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["HP_0000545"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1960."}
{"id":"CHEMBL1200371","canonicalSmiles":"CN[C@@H]1CCc2[nH]c3ccc(C(N)=O)cc3c2C1.O=C(O)CCC(=O)O","inchiKey":"WHTHWNUUXINXHN-SBSPUUFOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FROVATRIPTAN SUCCINATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1279","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Frova"],"synonyms":["SB-209509-AX","VML-251"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200397","canonicalSmiles":"CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12.Cl","inchiKey":"LJBSAUIFGPSHCN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTENAFINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL990","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lotrimin ultra","Mentax","Mentax-tc"],"synonyms":["Butenafine hydrochloride","KP-363"],"crossReferences":{"DailyMed":["butenafine%20hydrochloride"],"PubChem":["144206471"],"chEBI":["31325"]},"count":2,"approvedIndications":["EFO_0007510"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for tinea and has 1 investigational indication."}
{"id":"CHEMBL1200630","canonicalSmiles":"Cl.N[C@@H](CS)C(=O)O","inchiKey":"IFQSXNOEEPCSLW-DKWTVANSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYSTEINE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL863","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cysteine hydrochloride","Elcys","Nouress"],"synonyms":["Cysteine hydrochloride","Cysteine hydrochloride anhydrous","Cysteine hydrochloride monohydrate","L-cysteine","L-cysteine ethylester hydrochloride","L-cysteine hydrochloride hydrate","L-cysteinemethyl hydrochloride"],"crossReferences":{"DailyMed":["cysteine%20hydrochloride"],"PubChem":["144207897"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986 and has 1 investigational indication."}
{"id":"CHEMBL1200735","canonicalSmiles":"COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12.Cl","inchiKey":"IDIIJJHBXUESQI-DFIJPDEKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MOXIFLOXACIN HYDROCHLORIDE","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL32","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Avelox","Minims","Moxeza","Moxifloxacin hydrochloride","Moxivig","Vigamox"],"synonyms":["AL-15469A","BAY 12-8039","BAY-12-8039","Moxifloxacin hydrochloride"],"crossReferences":{"DailyMed":["moxifloxacin%20hydrochloride"],"PubChem":["144204992","170465209","49681620"],"chEBI":["7008"]},"count":11,"approvedIndications":["EFO_0003106","EFO_1000829","EFO_0006505"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 3 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200779","canonicalSmiles":"CS(=O)(=O)O.N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12","inchiKey":"DYNZICQDCVYXFW-AHZSKCOESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TROVAFLOXACIN MESYLATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL428","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Hepatotoxicity"],"year":1999},"tradeNames":["Trovan"],"synonyms":["CP-99,219-27","CP-99219-27","Trovafloxacin mesylate","Trovafloxacin sulfate"],"crossReferences":{"PubChem":["144204531","170465074"],"chEBI":["77568"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997. It was withdrawn in European Union and  United States initially in 1999 due to Hepatotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201005","canonicalSmiles":"O=C([O-])C1=C(CSc2nnnn2CS(=O)(=O)[O-])CS[C@@H]2[C@H](NC(=O)[C@H](O)c3ccccc3)C(=O)N12.[Na+].[Na+]","inchiKey":"NAXFZVGOZUWLEP-RFXDPDBWSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFONICID SODIUM","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1601","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Monocid"],"synonyms":["Cefonicid disodium salt","Cefonicid sodium","SK&F D-75073-Z2","SK&F-D-75073-Z2"],"crossReferences":{"PubChem":["144206015"],"chEBI":["3492"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1984 and has 1 investigational indication."}
{"id":"CHEMBL1201129","canonicalSmiles":"Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1","inchiKey":"XAUDJQYHKZQPEU-KVQBGUIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECITABINE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dacogen","Decitabine"],"synonyms":["DAC","Decitabine","NSC-127716"],"crossReferences":{"DailyMed":["decitabine"],"PubChem":["144205864","170465126","47211573","56324652","57260149"],"Wikipedia":["Decitabine"],"drugbank":["DB01262"],"chEBI":["50131"]},"count":50,"approvedIndications":["EFO_0000198","EFO_0000616","EFO_1001779","EFO_0000311","EFO_0003811"],"linkedTargets":{"rows":["ENSG00000130816","ENSG00000119772"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000756","EFO_0000681","EFO_1000131","EFO_0005952","EFO_1001951","EFO_0000565","EFO_0000309","EFO_0004251","EFO_0007160","EFO_0000339","EFO_0000096","MONDO_0003660","EFO_0000389","EFO_0000330","EFO_0000501","EFO_0000641","MONDO_0003659","EFO_0000198","EFO_0000220","EFO_0001642","MONDO_0008170","EFO_0002939","HP_0001873","EFO_0000224","MONDO_0100096","MONDO_0044917","MONDO_0019472","EFO_0002428","EFO_0000574","EFO_0001378","Orphanet_232","EFO_0002913","MONDO_0007254","EFO_1001945","EFO_1001469","MONDO_0002087","EFO_1000044","MONDO_0002158","EFO_1001996","EFO_1001830","EFO_0000196","EFO_0000183","MONDO_0020743","EFO_0002617","MONDO_0000430","EFO_0000616","EFO_1001779","EFO_0006859","MONDO_0019457","EFO_0000403","EFO_0000222","MONDO_0000870","EFO_0000621","EFO_0003060","EFO_0000311","EFO_1001934","EFO_0000211","EFO_0000304","EFO_0008549","EFO_0003811"],"count":61},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and has 5 approved and 45 investigational indications."}
{"id":"CHEMBL1201178","canonicalSmiles":"CS(=O)(=O)O.CS(=O)(=O)O.C[C@@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN","inchiKey":"CETWSOHVEGTIBR-FORAGAHYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LISDEXAMFETAMINE DIMESYLATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201222","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elvanse","Elvanse adult","Vyvanse"],"synonyms":["Lisdexamfetamine dimesylate","Lisdexamfetamine dimethanesulfonate","Lisdexamfetamine mesilate","NRP-104","NRP104","SPD-489","SPD489"],"crossReferences":{"DailyMed":["lisdexamfetamine%20dimesylate"]},"count":6,"approvedIndications":["EFO_0003888"],"linkedTargets":{"rows":["ENSG00000103546","ENSG00000142319","ENSG00000165646"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","EFO_0005204","MONDO_0002050","MONDO_0002009","EFO_0001073","EFO_0000692","EFO_0004698"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for attention deficit hyperactivity disorder and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201179","canonicalSmiles":"CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cc1ccc(S(=O)(=O)O)cc1.Cc1ccc(S(=O)(=O)O)cc1.O","inchiKey":"XNRVGTHNYCNCFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"LAPATINIB DITOSYLATE","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL554","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tykerb"],"synonyms":["GW-572016F","GW572016F","Lapatinib","Lapatinib ditoluenesulfonate monohydrate","Lapatinib ditosylate","Lapatinib ditosylate monohydrate","Lapatinib tosilate hydrate"],"crossReferences":{"DailyMed":["lapatinib%20ditosylate"]},"count":17,"approvedIndications":["EFO_0003869","MONDO_0007254","EFO_0000305"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_0003869","EFO_0006859","EFO_0000292","EFO_0002938","EFO_1001465","MONDO_0007254","EFO_1001512","EFO_0000402","EFO_0000504","EFO_0000305","MONDO_0008315","MONDO_0020654","MONDO_0001187","EFO_1001967","MONDO_0044787","EFO_0006861","EFO_0006352","EFO_0002892","EFO_0000574","MONDO_0024880","EFO_1000158","MONDO_0044926"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and has 3 approved and 14 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201260","canonicalSmiles":"C/N=C(\\NC)NCc1ccccc1","inchiKey":"NIVZHWNOUVJHKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETHANIDINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Betanidine","Bethanidine"],"crossReferences":{"Wikipedia":["Bethanidine"],"drugbank":["DB00217"],"chEBI":["37937"]},"childChemblIds":["CHEMBL2110368"],"count":1,"approvedIndications":["EFO_0000537"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0000537"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for hypertension."}
{"id":"CHEMBL1201320","canonicalSmiles":"COc1ccc2[nH]c([S@@+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1","inchiKey":"SUBDBMMJDZJVOS-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ESOMEPRAZOLE","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Emozul","Nexium","Nexium control","Nexium i.v.","Ventra"],"synonyms":["A02BC05","Esomeprazole","Omeprazole s-form"],"crossReferences":{"DailyMed":["esomeprazole%20magnesium","esomeprazole%20sodium","esomeprazole%20strontium"],"Wikipedia":["Esomeprazole"],"drugbank":["DB00736"],"chEBI":["50275"]},"childChemblIds":["CHEMBL1200470","CHEMBL2146140","CHEMBL2105642","CHEMBL2146133"],"count":29,"approvedIndications":["HP_0004398","EFO_0003948","MONDO_0004247"],"linkedTargets":{"rows":["ENSG00000105675"],"count":1},"linkedDiseases":{"rows":["EFO_0003869","EFO_0001361","HP_0001600","HP_0002239","Orphanet_586","MONDO_0043839","EFO_0003882","EFO_1001951","HP_0002018","HP_0004398","EFO_0003948","MONDO_0001056","EFO_0000337","EFO_0002506","MONDO_0004247","EFO_0000676","EFO_1000961","EFO_0000692","EFO_0005762","EFO_0000616","EFO_0000280","EFO_0000685","EFO_0003756","EFO_0000217","EFO_0001645","EFO_0003898","EFO_0003758","MONDO_0007576","EFO_0003929","EFO_0004607","EFO_0007549","EFO_1001355","EFO_0004239","EFO_0008533","EFO_0004232","EFO_0002609","EFO_0009454","MP_0001914","EFO_0001422","EFO_0010282","EFO_0000270","EFO_0000574","EFO_0000342","EFO_0001360","MONDO_0002647","EFO_0000668","EFO_1001095","HP_0100633"],"count":48},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and has 3 approved and 26 investigational indications."}
{"id":"CHEMBL1201340","canonicalSmiles":"C[N+]1(C)CCC(=C(c2ccccc2)c2ccccc2)CC1","inchiKey":"LCTZPQRFOZKZNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHEMANIL","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Diphemanil"],"crossReferences":{"PubChem":["11112168"],"drugbank":["DB13720"]},"childChemblIds":["CHEMBL1200880"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000168539"],"count":2},"linkedDiseases":{"rows":["EFO_0010282"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL1201574","drugType":"Unknown","blackBoxWarning":true,"name":"ONABOTULINUMTOXINA","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Botox","Botox cosmetic","Botox/botox cosmetic"],"synonyms":["Botulinum toxin","Botulinum toxin type a purified neurotoxin complex","Onabotulinumtoxina","Onaclostox","RTI-150","RTI150"],"crossReferences":{"DailyMed":["onabotulinumtoxina"]},"count":93,"linkedTargets":{"rows":["ENSG00000132639"],"count":1},"linkedDiseases":{"rows":["MONDO_0002507","HP_0001257","EFO_0009550","EFO_0000275","EFO_0006865","HP_0001760","EFO_1001909","HP_0001605","EFO_0005306","EFO_0007507","EFO_1000632","EFO_0004616","HP_0006986","EFO_0003877","EFO_0009453","EFO_0005762","MONDO_0000477","HP_0012532","EFO_1000906","HP_0009926","HP_0030016","EFO_0000546","GO_0007568","EFO_1000391","HP_0000951","EFO_0003830","EFO_0003108","EFO_1001434","EFO_1001887","EFO_1001896","EFO_0005687","HP_0000726","EFO_0000284","MONDO_0043839","EFO_1000948","HP_0012390","EFO_0009430","MONDO_0002050","EFO_0009462","HP_0000565","EFO_0004143","HP_0000577","EFO_1001092","HP_0000011","EFO_0009625","EFO_0003897","HP_0000486","Orphanet_93955","EFO_0004269","EFO_0002916","HP_0000473","HP_0002571","EFO_0000618","EFO_0001073","EFO_0003843","HP_0002315","EFO_0003885","HP_0001347","HP_0030839","HP_0003549","EFO_0006346","HP_0000020","HP_0000975","MONDO_0043510","EFO_0004270","EFO_0004191","HP_0000989","MONDO_0002009","EFO_1000657","EFO_1001919","EFO_1001145","EFO_0002506","MONDO_0002471","HP_0003419","EFO_0006510","EFO_0004208","EFO_0007159","EFO_1001250","HP_0000016","EFO_0005296","EFO_0001074","EFO_0003821","EFO_0002508","HP_0009762","EFO_1001466","EFO_0005422","MONDO_0004001","EFO_1000999","HP_0040083","EFO_0002970","EFO_1001219","EFO_1001494","EFO_0004234","EFO_0008507","EFO_0009846","EFO_0003911","HP_0030834","EFO_0000712","EFO_0009619","EFO_1001993","EFO_1000850","HP_0001822","EFO_0005230","EFO_0008521","HP_0001337","Orphanet_523","EFO_1001054","EFO_0003894","Orphanet_98578","EFO_1001762","EFO_1000781","EFO_0009523","EFO_0004149","HP_0002307","HP_0002019"],"count":115},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 93 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201628","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN SUSP PROTAMINE ZINC BEEF/PORK","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Protamine zinc & iletin i (beef-pork)"],"synonyms":["Insulin susp protamine zinc beef/pork"],"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1966."}
{"id":"CHEMBL1201633","drugType":"Enzyme","blackBoxWarning":false,"name":"ALGLUCERASE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceredase"],"synonyms":["Alglucerase"],"crossReferences":{"DrugCentral":["5129"],"Wikipedia":["Alglucerase"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 1991."}
{"id":"CHEMBL1201766","canonicalSmiles":"CC(C)c1cccc(C(C)C)c1OCOP(=O)(O)O","inchiKey":"QVNNONOFASOXQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSPROPOFOL","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Fospropofol"],"crossReferences":{"Wikipedia":["Fospropofol"],"drugbank":["DB06716"]},"childChemblIds":["CHEMBL2021422"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2008."}
{"id":"CHEMBL1213412","canonicalSmiles":"O=C(O)c1ccc(/C=N/OCCO/N=C/c2cc(=O)[nH]c(=O)[nH]2)cc1","inchiKey":"XHDKIDMFBWLHAX-GONBZBRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213412","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06990"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1214124","canonicalSmiles":"N#Cc1ccccc1-c1cc(-c2ccccn2)cn(-c2ccccc2)c1=O","inchiKey":"PRMWGUBFXWROHD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PERAMPANEL","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fycompa"],"synonyms":["E-2007","E2007","ER-155055-90","Perampanel"],"crossReferences":{"DailyMed":["perampanel"],"Wikipedia":["Perampanel"],"drugbank":["DB08883"],"chEBI":["71013"]},"count":17,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000125675","ENSG00000120251","ENSG00000155511","ENSG00000152578"],"count":4},"linkedDiseases":{"rows":["HP_0002069","MONDO_0002009","EFO_0002508","EFO_0003821","HP_0000473","EFO_0001358","HP_0001250","Orphanet_2382","EFO_0003829","EFO_1000783","EFO_0000474","EFO_0000289","EFO_0009430","EFO_0000253","EFO_0004149","EFO_0007262","EFO_0003833","EFO_0003108"],"count":18},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2012 and is indicated for epilepsy and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1229742","canonicalSmiles":"CC(C)[C@@]1(C)N=C(c2nc3ccccc3cc2C(=O)O)NC1=O","inchiKey":"CABMTIJINOIHOD-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(R)-IMAZAQUIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04582"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231535","canonicalSmiles":"O=C(O)[C@@H](Cc1ccccc1)[C@H](Cc1ccc2c(c1)OCO2)C(=O)O","inchiKey":"ASEJDWRSZYAIOT-GJZGRUSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231535","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02450"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231666","canonicalSmiles":"O=C(NNS(=O)(=O)c1ccccc1C(F)(F)F)c1cc2cc(Cl)ccc2o1","inchiKey":"ZLQBZYKAQQWOTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231666","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07544"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232180","canonicalSmiles":"Nc1ncnc2c(CN3C[C@H](CSCc4ccccc4)[C@@H](O)C3)c[nH]c12","inchiKey":"DIGGNILBPCEZIV-CVEARBPZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232180","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07649"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232699","canonicalSmiles":"O=C(O)c1ccccc1C1c2ccc(O)cc2Oc2cc(O)ccc21","inchiKey":"MURGITYSBWUQTI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUORESCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dihydrofluorescein"],"crossReferences":{"drugbank":["DB07764"],"chEBI":["42492"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236582","canonicalSmiles":"CCCCCCCCCC(C)=O","inchiKey":"KYWIYKKSMDLRDC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYL NONYL KETONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08688"],"chEBI":["17700"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL123850","canonicalSmiles":"CNC(=O)[C@@H](NC(=O)[C@H](OCc1ccc(-c2cccnc2)cc1)[C@H](O)[C@@H](O)[C@@H](OCc1ccc(-c2cccnc2)cc1)C(=O)N[C@H](C(=O)NC)C(C)C)C(C)C","inchiKey":"FOBRXMROTNVGST-CXPJILFNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL123850","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02683"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1241","canonicalSmiles":"CN(C)CCN(Cc1ccccc1)c1ccccn1","inchiKey":"UFLGIAIHIAPJJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPELENNAMINE","yearOfFirstApproval":1948,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["PBZ","PBZ-SR","Tripelennamine"],"crossReferences":{"Wikipedia":["Tripelennamine"],"drugbank":["DB00792"],"chEBI":["9741"]},"childChemblIds":["CHEMBL1200769","CHEMBL1200446"],"count":2,"approvedIndications":["HP_0000989","EFO_0003785"],"linkedTargets":{"rows":["ENSG00000196639"],"count":1},"linkedDiseases":{"rows":["HP_0000989","EFO_0003785"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1948 and is indicated for pruritus and allergy."}
{"id":"CHEMBL1255794","canonicalSmiles":"CCCCN1C(=O)[C@@H]([C@H](O)C2CCCCC2)NC(=O)C12CCN(Cc1ccc(Oc3ccc(C(=O)O)cc3)cc1)CC2","inchiKey":"GWNOTCOIYUNTQP-FQLXRVMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APLAVIROC","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aplaviroc"],"crossReferences":{"drugbank":["DB06497"]},"childChemblIds":["CHEMBL1668019"],"linkedTargets":{"rows":["ENSG00000160791"],"count":1},"linkedDiseases":{"rows":["EFO_0000764"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL1258006","canonicalSmiles":"O=C(N[C@@H]1C2CCN(CC2)[C@H]1Cc1cccnc1)c1cc2ccccc2o1","inchiKey":"OXKRFEWMSWPKKV-GHTZIAJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRADANICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATA-101","Bradanicline","TC 5619","TC-5619"],"crossReferences":{"drugbank":["DB06090"]},"childChemblIds":["CHEMBL3137311"],"count":3,"linkedTargets":{"rows":["ENSG00000175344"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","HP_0012735","EFO_0000692"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL137","canonicalSmiles":"Cc1ncc([N+](=O)[O-])n1CCO","inchiKey":"VAOCPAMSLUNLGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METRONIDAZOLE","yearOfFirstApproval":1963,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acea","Anabact","Drazifon","Elyzol","Flagyl","Flagyl 375","Flagyl I.V. Rtu In Plastic Container","Flagyl compak","Flagyl er","Flagyl-400","Flagyl-s","Metric 21","Metro i.v.","Metrocream","Metrogel","Metrogel-vaginal","Metrolotion","Metrolyl","Metromidol","Metronidazole","Metrosa","Metrotop","Neutratop","Noritate","Norzol","Nuvessa","Protostat","Rosiced","Rozex","Satric","Vaginyl","Vandazole","Zadstat","Zidoval","Zyomet"],"synonyms":["BAY-5360","BAYER 5360","BAYER-5360","Metronidazole","NSC-50364","NSC-69587","RP 8823","RP-8823"],"crossReferences":{"DailyMed":["metronidazole"],"PubChem":["104171304","11112343","144203992","144209611","144213111","170464948","17389815","174006204","26719631","855672"],"Wikipedia":["Metronidazole"],"drugbank":["DB00916"],"chEBI":["6909"]},"childChemblIds":["CHEMBL1200869"],"count":40,"approvedIndications":["EFO_0003106","EFO_1000760","EFO_0000771","EFO_0000544","EFO_0003932","EFO_0004607"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1963 and has 6 approved and 34 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1425","canonicalSmiles":"Sc1ncnc2nc[nH]c12","inchiKey":"GLVAUDGFNGKCSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERCAPTOPURINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Purinethol"],"synonyms":["Mercaptopurine","Mercaptopurine anhydrous"],"crossReferences":{"DailyMed":["mercaptopurine"],"PubChem":["124891196","144204709","144209789","170464985","174006957","26748122","49675007","50086850","538245"],"Wikipedia":["Mercaptopurine"],"drugbank":["DB01033"],"chEBI":["2208"]},"childChemblIds":["CHEMBL1200751"],"linkedTargets":{"rows":["ENSG00000128059"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","MONDO_0000873","EFO_0000209","MONDO_0003541","EFO_0000565","EFO_1000318","MONDO_0003268","MONDO_0019460","EFO_0004289","EFO_0000330","EFO_0002499","MONDO_0020743","EFO_0000094","EFO_0010580","EFO_0000616","EFO_0000220","EFO_0000222","MONDO_0000870","EFO_1001946","EFO_0002501","EFO_0000384","EFO_0000224","MONDO_0044917","EFO_1001936","EFO_1001947","EFO_0000574","EFO_0000519","EFO_0003872"],"count":28},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL14370","canonicalSmiles":"CCOc1ccccc1OC(c1ccccc1)C1CNCCO1","inchiKey":"CBQGYUDMJHNJBX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REBOXETINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Edronax"],"synonyms":["Reboxetine"],"crossReferences":{"Wikipedia":["Reboxetine"]},"childChemblIds":["CHEMBL2146087"],"count":9,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000103546"],"count":1},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005687","MONDO_0002050","MONDO_0002009","HP_0000726","EFO_0000712","EFO_0003761","EFO_0005230","EFO_0000692","EFO_0003843"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for unipolar depression and has 8 investigational indications."}
{"id":"CHEMBL1446813","canonicalSmiles":"CNCCc1ccccn1.Cl.Cl","inchiKey":"XVDFMHARQUBJRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAHISTINE HYDROCHLORIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL24441","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Serc","Serc-16","Serc-8"],"synonyms":["Betahistine dihydrochloride","Betahistine hydrochloride","PT-9"],"crossReferences":{"PubChem":["26749927"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1464005","canonicalSmiles":"CC(C)[N+]1(C)[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2.[Br-]","inchiKey":"LHLMOSXCXGLMMN-WDTICOSOSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"IPRATROPIUM BROMIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1621597","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ipratropium Bromide"],"crossReferences":{"PubChem":["855799"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1514","canonicalSmiles":"CC[C@H](OC(C)=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"XBMIVRRWGCYBTQ-AVRDEDQJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOMETHADYL ACETATE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["European Union"," United States"],"classes":["Cardiotoxicity"],"year":2001},"tradeNames":[],"synonyms":["LAA-M","LAAM","Levacetylmethadol","Levomethadyl acetate"],"crossReferences":{"Wikipedia":["Levacetylmethadol"],"drugbank":["DB01227"],"chEBI":["6441"]},"childChemblIds":["CHEMBL1200817"],"count":2,"approvedIndications":["EFO_0003890"],"linkedTargets":{"rows":["ENSG00000112038"],"count":1},"linkedDiseases":{"rows":["EFO_0003890","EFO_0005611"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and is indicated for drug dependence and has 1 investigational indication. It was withdrawn in European Union and  United States initially in 2001 due to Cardiotoxicity."}
{"id":"CHEMBL153813","canonicalSmiles":"CC(C)C[C@H](NC(=O)N1CCOCC1)C(=O)N[C@H](C#N)COCc1ccccc1","inchiKey":"LXEDKIMJQBOMSU-MOPGFXCFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL153813","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL159660","canonicalSmiles":"CC[C@@H](O)C(C[C@@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"QIRAYNIFEOXSPW-YLJYHZDGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALPHAMETHADOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alphamethadol"],"crossReferences":{"drugbank":["DB01498"]},"childChemblIds":["CHEMBL2354908"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1616046","canonicalSmiles":"OCl","inchiKey":"QWPPOHNGKGFGJK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYPOCHLOROUS ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hypochlorous acid"],"crossReferences":{"drugbank":["DB14135"],"chEBI":["24757"]},"childChemblIds":["CHEMBL1334078","CHEMBL2251447"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1697838","canonicalSmiles":"COCCOc1cnc(NS(=O)(=O)c2ccccc2)nc1","inchiKey":"QFWPJPIVLCBXFJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYMIDINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gondafon","Redul"],"synonyms":["Glymidine"],"crossReferences":{"Wikipedia":["Glymidine_sodium"],"drugbank":["DB01382"]},"childChemblIds":["CHEMBL2103771"],"count":1,"approvedIndications":["EFO_0000400"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for diabetes mellitus."}
{"id":"CHEMBL1704605","canonicalSmiles":"CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1.Cl","inchiKey":"XRSCTTPDKURIIJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1704605","maximumClinicalTrialPhase":0,"parentId":"CHEMBL121","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["49681567"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1721359","canonicalSmiles":"O=[N+]([O-])c1ccc([As](=O)(O)O)cc1","inchiKey":"FUUFQLXAIUOWML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1721359","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206311","144212591","170465716","50125868"],"drugbank":["DB11437"],"chEBI":["62629"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL173562","canonicalSmiles":"O=C(OCCO)c1ccccc1O","inchiKey":"LVYLCBNXHHHPSB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSC-72097","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-72097"],"crossReferences":{"PubChem":["144207011","225144223"],"drugbank":["DB11323"],"chEBI":["86541"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL173809","canonicalSmiles":"CC(C)C(C#N)(CCCN(C)CCc1ccccc1)c1ccccc1","inchiKey":"DWAWDSVKAUWFHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMOPAMIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emopamil"],"crossReferences":{"Wikipedia":["Emopamil"],"drugbank":["DB14064"],"chEBI":["34736"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1742981","drugType":"Antibody","blackBoxWarning":false,"name":"ABAGOVOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACA-125","Abagovomab","MEN-2234"],"count":3,"linkedTargets":{"rows":["ENSG00000181143"],"count":1},"linkedDiseases":{"rows":["MONDO_0002158","MONDO_0008170","MONDO_0002087"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL177591","canonicalSmiles":"CN(C)C(=O)O","inchiKey":"DWLVWMUCHSLGSU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYLCARBATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethyl-Carbamic Acid","Dimethylcarbate"],"crossReferences":{"chEBI":["38544"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1800159","canonicalSmiles":"CONC(=O)Nc1ccc(-c2sc3c(c2CN(C)C)c(=O)n(-c2ccc(OC)nn2)c(=O)n3Cc2c(F)cccc2F)cc1","inchiKey":"AOMXMOCNKJTRQP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELUGOLIX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Relugolix","TAK-385","Tak-385"],"crossReferences":{"drugbank":["DB11853"]},"count":4,"linkedTargets":{"rows":["ENSG00000109163"],"count":1},"linkedDiseases":{"rows":["EFO_0000731","EFO_0001065","EFO_0003843","MONDO_0008315"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL185878","canonicalSmiles":"C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](CC[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O","inchiKey":"BHTRKEVKTKCXOH-BJLOMENOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAUROCHENODEOXYCHOLATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Taurochenodeoxycholic acid"],"crossReferences":{"Wikipedia":["Taurochenodeoxycholic_acid"],"drugbank":["DB08833"],"chEBI":["16525"]},"childChemblIds":["CHEMBL2028546"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1867342","canonicalSmiles":"C=CCOC(=O)C(C)(C)OC(=O)c1cc(-n2c(=O)cc(C(F)(F)F)n(C)c2=O)ccc1Cl","inchiKey":"JEDYYFXHPAIBGR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTAFENACIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211463","50113090"],"drugbank":["DB15261"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1870796","canonicalSmiles":"CC(C)(C)C(=O)NCCCC(=O)O","inchiKey":"SRPNQDXRVRCTNK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIVAGABINE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CXB-722","CXB722","Cxb722","Pivagabine"],"crossReferences":{"PubChem":["170466354","29216139"],"drugbank":["DB12951"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1875805","canonicalSmiles":"CC(=O)NC(CC(C)C)C(=O)O","inchiKey":"WXNXCEHXYPACJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETYLLEUCINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetylleucine"],"crossReferences":{"PubChem":["93576639"],"drugbank":["DB13226"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL190801","canonicalSmiles":"O=C1CN(c2ccccc2)S(=O)(=O)N1","inchiKey":"LDCZCUKQWRZSDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL190801","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1908325","canonicalSmiles":"CO[C@H]1C[C@H](O[C@@H]2/C(C)=C/C[C@@H]3C[C@@H](C[C@]4(CC[C@H](C)[C@@H](C5CCCCC5)O4)O3)OC(=O)[C@@H]3C=C(C)/C(=N/O)[C@H]4OC/C(=C\\C=C\\[C@@H]2C)[C@@]34O)O[C@@H](C)[C@@H]1O","inchiKey":"AFJYYKSVHJGXSN-XHKIUTQPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELAMECTIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Selamectin","UK-124,114"],"crossReferences":{"PubChem":["144204961"],"drugbank":["DB11459"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1922660","canonicalSmiles":"CCOc1ccc(-c2ccc(Cn3c(CC(C)(C)C(=O)O)c(SC(C)(C)C)c4cc(OCc5ccc(C)cn5)ccc43)cc2)cn1","inchiKey":"DFQGDHBGRSTTHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIBOFLAPON","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AM-803","Fiboflapon","GSK-2190915","GSK2190915","GSK2190915B"],"crossReferences":{"drugbank":["DB06346"]},"childChemblIds":["CHEMBL1922673"],"count":1,"linkedTargets":{"rows":["ENSG00000132965"],"count":1},"linkedDiseases":{"rows":["EFO_0000289","EFO_0000270","Orphanet_586","EFO_1001348"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1951143","canonicalSmiles":"CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1","inchiKey":"AMEROGPZOLAFBN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIMASARTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fimasartan"],"crossReferences":{"drugbank":["DB09279"]},"childChemblIds":["CHEMBL1951146"],"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2058833","canonicalSmiles":"CC1(C)c2nc(-c3ccc(F)cc3)c(Nc3ccc(F)cc3)n2CCN1C(=O)CN","inchiKey":"BUPRVECGWBHCQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GANAPLACIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF 156","GNF-156","Ganaplacide","KAF 156","KAF-156","KAF156","Kaf156"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2095224","canonicalSmiles":"COc1ccc2nc3cc(Cl)ccc3c(Nc3cc(CN4CCCC4)c(O)c(CN4CCCC4)c3)c2n1.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"YKUQEKXHQFYULM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRONARIDINE TETRAPHOSPHATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL35228","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyronaridine phosphate","Pyronaridine tetraphosphate"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2104698","canonicalSmiles":"CN(C)CCO[C@]1(c2ccccc2)C[C@H]2CC[C@]1(C)C2(C)C","inchiKey":"QOBGWWQAMAPULA-RLLQIKCJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERAMCICLANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deramciclane"],"crossReferences":{"drugbank":["DB06512"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104993","canonicalSmiles":"Cc1ccc(Sc2ccccc2N2CCNCC2)c(C)c1","inchiKey":"YQNWZWMKLDQSAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"VORTIOXETINE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Brintellix"],"synonyms":["LU AA21004","LU-AA21004","LUAA21004","Vortioxetine"],"crossReferences":{"DailyMed":["vortioxetine%20hydrobromide"],"drugbank":["DB09068"],"chEBI":["76016"]},"childChemblIds":["CHEMBL2107387","CHEMBL3260563","CHEMBL2204360"],"count":6,"approvedIndications":["EFO_0003761"],"linkedTargets":{"rows":["ENSG00000178394","ENSG00000108576","ENSG00000166736"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0005203","EFO_1001892","EFO_0000289","MONDO_0002050","EFO_0004262","MONDO_0002009","EFO_0001421","HP_0001268","EFO_0003761","EFO_0001358","EFO_0005230","EFO_0000692"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for unipolar depression and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105348","canonicalSmiles":"CO[C@H]1O[C@H](CNC(=O)N(CCCl)N=O)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"AHHFEZNOXOZZQA-ZEBDFXRSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RANIMUSTINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-270516","Ranimustine"],"crossReferences":{"drugbank":["DB13832"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105632","canonicalSmiles":"CC[C@H](C)OC(=O)Cc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1.O=C(O)C(O)C(O)C(=O)O","inchiKey":"CAMFTHAPYYLIIG-LMOVPXPDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUDIODARONE TARTRATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2105631","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ATI-2042","Budiodarone tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105756","canonicalSmiles":"COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC.Cl.O","inchiKey":"RQXMKRRBJITKRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIVOZANIB HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1289494","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AV-951","Tivozanib hydrochloride","Tivozanib hydrochloride monohydrate"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105872","canonicalSmiles":"CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N1CCC2(CC1)CN(S(C)(=O)=O)c1ccccc12.CS(=O)(=O)O","inchiKey":"DUGMCDWNXXFHDE-VZYDHVRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IBUTAMOREN MESYLATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL13817","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ibutamoren mesylate","MK-0677","MK-677"],"count":1,"linkedTargets":{"rows":["ENSG00000121853"],"count":1},"linkedDiseases":{"rows":["EFO_0005687"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2106191","canonicalSmiles":"O=S(=O)([O-])c1cc(O)ccc1O.O=S(=O)([O-])c1cc(O)ccc1O.[Ca+2]","inchiKey":"QGNBTYAQAPLTMX-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CALCIUM DOBESILATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1232131","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Doxium","Doxium 500"],"synonyms":["205 E","205-E","Calcium dobesilate","Calcium doxybensylate","Dobesilate calcium"],"crossReferences":{"DrugCentral":["936"]},"count":5,"approvedIndications":["HP_0002619"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for varicose veins and has 4 investigational indications."}
{"id":"CHEMBL2106240","canonicalSmiles":"C[C@]12CC[C@@H]3c4ccc(OS(=O)(=O)[O-])cc4CC[C@H]3[C@@H]1CCC2=O.[Na+]","inchiKey":"VUCAHVBMSFIGAI-ZFINNJDLSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"ESTRONE SODIUM SULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL494753","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Estrone sodium sulfate"],"crossReferences":{"chEBI":["8389"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2106325","canonicalSmiles":"Cc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3","inchiKey":"KBEZZLAAKIIPFK-NJAFHUGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMEMORFAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimemorfan","Dimemorfan phosphate"],"crossReferences":{"drugbank":["DB13810"]},"childChemblIds":["CHEMBL3188434"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106975","canonicalSmiles":"O=C([O-])O.[K+]","inchiKey":"TYJJADVDDVDEDZ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"POTASSIUM BICARBONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pot eff"],"synonyms":["Potassium bicarbonate","Potassium hydrogencarbonate"],"crossReferences":{"DrugCentral":["4520"],"drugbank":["DB11098"],"chEBI":["81862"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107378","canonicalSmiles":"C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1.C1CCC2(C1)[C@H]1CN(CC3CC3)C[C@@H]2CN(CC2CC2)C1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O","inchiKey":"AZPYPAVFNGFTGB-ORRJWUSCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEDISAMIL SESQUIFUMARATE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL2111110","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["KC-8857 SESQUIFUMARATE","KC8857","Tedisamil sesquifumarate"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107786","canonicalSmiles":"Cc1ccc2c(c1CCC(=O)O)CC[C@@H](NS(=O)(=O)c1ccc(Cl)cc1)C2","inchiKey":"HWEOXFSBSQIWSY-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERUTROBAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Triplion"],"synonyms":["S18886","Terutroban"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2107910","drugType":"Small molecule","blackBoxWarning":true,"name":"OLIVE OIL","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Olea europaea fruit oil","Olea europaea oil","Olive oil"],"count":12,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and has 12 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108029","drugType":"Antibody","blackBoxWarning":false,"name":"ERTUMAXOMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Rexomun"],"synonyms":["Ertumaxomab"],"count":2,"linkedTargets":{"rows":["ENSG00000141736","ENSG00000198851"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108161","drugType":"Unknown","blackBoxWarning":false,"name":"TUBERCULIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Aplisol","Aplitest","Tine test","Tine test ppd"],"synonyms":["Tuberculin","Tuberculin, old","Tuberculin, purified protein derivative of"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108209","drugType":"Unknown","blackBoxWarning":false,"name":"LENTINAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LC 33","LC-33","Lentinan"],"crossReferences":{"DrugCentral":["2987"]},"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108396","drugType":"Protein","blackBoxWarning":false,"name":"DEFIBROTIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Defibrotide"],"crossReferences":{"DrugCentral":["5092"]},"count":6,"approvedIndications":["HP_0004419"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for recurrent thrombophlebitis and has 5 investigational indications."}
{"id":"CHEMBL2108448","drugType":"Oligosaccharide","blackBoxWarning":true,"name":"HETASTARCH","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Hespan"],"synonyms":["Hetastarch","Hydroxyethylstarch"],"count":2,"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108573","drugType":"Unknown","blackBoxWarning":false,"name":"ANTHRAX VACCINE ABSORBED","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anthrax antigen","Anthrax vaccine absorbed"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108922","drugType":"Unknown","blackBoxWarning":false,"name":"CHONDROITIN SULFATE SODIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chondroitin sulfate","Chondroitin sulfate sodium"],"crossReferences":{"DrugCentral":["4103"]},"count":4,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109001","drugType":"Unknown","blackBoxWarning":false,"name":"CARBOXYMETHYLCELLULOSE SODIUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Blandlax","Cellufresh","Celluvisc","Gppe paste","Orabase","Refresh plus, cellufresh formula"],"synonyms":["Carboxymethylcellulose sodium","Carmellose sodium","E 466","E 468"],"count":4,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL2109124","drugType":"Antibody","blackBoxWarning":false,"name":"DORLIMOMAB ARITOX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dorlimomab aritox","MDX-RA","ST-1 4197X-RA"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2109590","drugType":"Antibody","blackBoxWarning":false,"name":"GSK-1995057","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-1995057","Gsk-1995057"],"count":1,"linkedTargets":{"rows":["ENSG00000067182"],"count":1},"linkedDiseases":{"rows":["EFO_0000684"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2110674","canonicalSmiles":"CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)O)O[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"WCDDVEOXEIYWFB-VXORFPGASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYALURONATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Hyaluronate","Hyaluronic acid"],"childChemblIds":["CHEMBL2105008"],"count":9,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2110679","canonicalSmiles":"CCOC(=O)c1ncn2c1CN(C)C(=O)c1c(I)cccc1-2","inchiKey":"FRIZVHMAECRUBR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IOMAZENIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iomazenil","RO 16-0154","RO-16-0154","RO16-0154"],"crossReferences":{"PubChem":["144206800"],"drugbank":["DB14971"]},"childChemblIds":["CHEMBL2105020"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL216579","canonicalSmiles":"O=C(c1ccc2[nH]ccc2c1)N1CCN(C2c3ccccc3-c3ccccc32)CC1","inchiKey":"YYMZSGIXLQPFAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL216579","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04289"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2181367","canonicalSmiles":"C[C@H](NP(=O)(OC[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)C[C@@H]1O)Oc1cccc2ccccc12)C(=O)OCc1ccccc1","inchiKey":"BIOWRMNRHMERIO-ZVAHOJSLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSIFLOXURIDINE NAFALBENAMIDE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosifloxuridine nafalbenamide","NUC-3373","Nuc-3373"],"crossReferences":{"drugbank":["DB14859"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL220346","canonicalSmiles":"Nc1ncccc1NCc1cccc(-c2cccnc2)c1","inchiKey":"NQSBHBFOOVYRNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL220346","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07284"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2218911","canonicalSmiles":"C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO","inchiKey":"TXIOIJSYWOLKNU-FLQODOFBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEVIRIMAT DIMEGLUMINE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL404519","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bevirimat dimeglumine","Bevirimat dimeglumine salt","DSB*2NMG","PA-103001-01","PA-103001-04","PA-457","PA-457 DI-NMG","PA-457N","PA103001","PA103001-01","PA103001-04"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL229855","canonicalSmiles":"Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccc(Br)cc4)c3)cc12","inchiKey":"VLPMRZSKJUTRBQ-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL229855","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08569"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL230137","canonicalSmiles":"CCN1CCN(c2nc(Nc3ccccc3)n3ncc(C#N)c3n2)CC1","inchiKey":"BIFHJPUTQBOBGJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL230137","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08360"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2311152","canonicalSmiles":"[3H][C@](O)(CN)c1ccc(O)c(O)c1","inchiKey":"SFLSHLFXELFNJZ-CMIMLBRMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[3H]NOREPINEPHRINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1437","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["[3H]-Norepinephrine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364648","drugType":"Antibody","blackBoxWarning":false,"name":"GUSELKUMAB","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tremfya"],"synonyms":["CNTO 1959","CNTO-1959","Guselkumab"],"crossReferences":{"DailyMed":["guselkumab"]},"count":9,"approvedIndications":["EFO_0000676","Orphanet_163927","EFO_0000540"],"linkedTargets":{"rows":["ENSG00000110944"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000685","EFO_0005761","EFO_1000710","EFO_1001494","EFO_0003778","Orphanet_163927","EFO_0000540","EFO_0000384","EFO_1001209","Orphanet_247353","Orphanet_733","Orphanet_2897","EFO_0000676"],"count":14},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and has 3 approved and 6 investigational indications."}
{"id":"CHEMBL2365807","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(C(C)Cc2cccs2)CC1","inchiKey":"YPOXDUYRRSUFFG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL2365807","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01470"]},"childChemblIds":["CHEMBL2358736"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL243024","canonicalSmiles":"CC#CCOc1ccc(S(=O)(=O)N2CC[C@H](S)C2)cc1","inchiKey":"BLIQFUCBRCDFAI-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL243024","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06943"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL24787","canonicalSmiles":"CC[C@H]1COC(c2ccc(OCCCCCCCc3cc(C)no3)cc2)=N1","inchiKey":"PZDSRPCFNWOUFP-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL24787","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08725"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL272198","canonicalSmiles":"COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC","inchiKey":"ZATGFXTWDKIEKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL272198","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07274"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL277062","canonicalSmiles":"O=C1CN=C(c2ccccn2)c2cc(Br)ccc2N1","inchiKey":"VMIYHDSEFNYJSL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMAZEPAM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lectopam","Lexotan"],"synonyms":["Bromazepam","Bromazepam civ","NSC-140669","RO 5-3350","RO-5-3350"],"crossReferences":{"Wikipedia":["Bromazepam"],"drugbank":["DB01558"]},"count":4,"approvedIndications":["EFO_0005230"],"linkedTargets":{"rows":["ENSG00000151834"],"count":1},"linkedDiseases":{"rows":["MONDO_0002050","HP_0000726","EFO_0005230","EFO_0000692"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for anxiety and has 3 investigational indications."}
{"id":"CHEMBL27769","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"NVKAWKQGWWIWPM-ABEVXSGRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"STANOLONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Neodrol"],"synonyms":["5alpha-dihydrotestosterone","Androstanolone","NSC-10972","Stanolone"],"crossReferences":{"PubChem":["144204607","144208185","144213957","17389515","50086823"],"Wikipedia":["Dihydrotestosterone"],"drugbank":["DB02901"],"chEBI":["16330"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL289469","canonicalSmiles":"CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2","inchiKey":"MFWNKCLOYSRHCJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRANISETRON","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kytril","Sancuso","Sustol"],"synonyms":["APF-530","APF530","BRL 43694","BRL-43694","Granisetron","LY-278584"],"crossReferences":{"DailyMed":["granisetron","granisetron%20hydrochloride"],"PubChem":["90340785"]},"childChemblIds":["CHEMBL1237080"],"count":12,"approvedIndications":["EFO_0006911","HP_0002017","EFO_0004888","HP_0002018"],"linkedTargets":{"rows":["ENSG00000166736"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0004799","HP_0000989","EFO_0006911","EFO_1000948","EFO_0003843","MONDO_0008315","EFO_0000311","HP_0002018","EFO_0000565","HP_0100806","MONDO_0015917","HP_0005184","EFO_0001061","EFO_0007359","HP_0002017","EFO_0004888","EFO_0000574","HP_0002013","EFO_0005251"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 4 approved and 8 investigational indications."}
{"id":"CHEMBL290814","canonicalSmiles":"CO/C1=C\\C(C)=C\\[C@@H](C)[C@@H](O)[C@@H](C)C/C(C)=C/C=C/[C@H](OC)[C@@H]([C@@H](C)[C@@H](O)[C@H](C)[C@@]2(O)C[C@@H](O)[C@H](C)[C@@H](C(C)C)O2)OC1=O","inchiKey":"XDHNQDDQEHDUTM-JQWOJBOSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAFILOMYCIN A1","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bafilomycin A1"],"crossReferences":{"Wikipedia":["Bafilomycin"],"drugbank":["DB06733"],"chEBI":["22689"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL294018","canonicalSmiles":"O=C1C=C2C(=CCOC2O)O1","inchiKey":"ZRWPUFFVAOMMNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PATULIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SCH-351633"],"crossReferences":{"PubChem":["26749249","26753752","73831"],"Wikipedia":["Patulin"],"drugbank":["DB15586"],"chEBI":["74926"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL296035","canonicalSmiles":"CCc1cccc2cc(C(O)CNC(C)(C)C)oc12","inchiKey":"SSEBTPPFLLCUMN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFURALOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bufuralol"],"crossReferences":{"PubChem":["29217723"],"Wikipedia":["Bufuralol"],"drugbank":["DB06726"],"chEBI":["34593"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL298817","canonicalSmiles":"C[C@@H](n1cnc2cc(Cl)ccc2c1=O)[C@](O)(Cn1cncn1)c1ccc(F)cc1F","inchiKey":"UHIXWHUVLCAJQL-MPBGBICISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBACONAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albaconazole","UR-9825","W-0027","W0027"],"crossReferences":{"Wikipedia":["Albaconazole"],"drugbank":["DB12073"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3039525","canonicalSmiles":"CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1","inchiKey":"UQRCJCNVNUFYDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLVATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E-7050","E7050","Golvatinib"],"crossReferences":{"drugbank":["DB11977"]},"childChemblIds":["CHEMBL3039500"],"count":4,"linkedTargets":{"rows":["ENSG00000128052","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3039564","drugType":"Small molecule","blackBoxWarning":false,"name":"IRINOTECAN SUCROSOFATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irinotecan sucrosofate","MM-398","PEP-02"],"count":2,"linkedTargets":{"rows":["ENSG00000198900"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000616","EFO_1000044","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3039598","canonicalSmiles":"CCC(=O)O[C@@H](O[P@](=O)(CCCCc1ccccc1)CC(=O)N1C[C@H](C2CCCCC2)C[C@H]1C(=O)O)C(C)C","inchiKey":"BIDNLKIUORFRQP-XYGFDPSESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FOSINOPRIL","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Monopril"],"synonyms":["C09AA09","Fosinopril","SQ-28555"],"crossReferences":{"DailyMed":["fosinopril%20sodium"],"drugbank":["DB00492"]},"childChemblIds":["CHEMBL3039596"],"count":4,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000401","EFO_0003884","EFO_0000319","EFO_0000341","EFO_0000537"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and is indicated for cardiovascular disease and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3092650","canonicalSmiles":"O=C1CCCN1c1ccc(Oc2ccc3c(c2)CCN(C2CCC2)CC3)nc1","inchiKey":"YFRBKEVUUCQYOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK239512","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-239512A","GSK239512","Gsk239512"],"crossReferences":{"drugbank":["DB15120"]},"count":5,"linkedTargets":{"rows":["ENSG00000101180"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","HP_0000726","EFO_0000249","EFO_0003929","EFO_0000692"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3137312","canonicalSmiles":"COc1c(-c2ccc3cc(NS(C)(=O)=O)ccc3c2)cc(-n2ccc(=O)[nH]c2=O)cc1C(C)(C)C","inchiKey":"NBRBXGKOEOGLOI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DASABUVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exviera"],"synonyms":["ABT-333","Dasabuvir"],"crossReferences":{"drugbank":["DB09183"],"chEBI":["85182"]},"childChemblIds":["CHEMBL3544985"],"count":5,"approvedIndications":["EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for viral disease and has 4 investigational indications."}
{"id":"CHEMBL31574","canonicalSmiles":"O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)ccc12","inchiKey":"XHEFDIBZLJXQHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FISETIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fisetin","NSC-407010","NSC-656275"],"crossReferences":{"PubChem":["11113262","11113263","124883071","124883072","26749675","26753766","476876"],"Wikipedia":["Fisetin"],"drugbank":["DB07795"],"chEBI":["42567"]},"childChemblIds":["CHEMBL1728023"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL316048","canonicalSmiles":"C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@@H](O)CC[C@@]43C)[C@@H]1CC[C@@H]2O","inchiKey":"CBMYJHIOYJEBSB-YSZCXEEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANDROSTANEDIOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["androstanediol "],"crossReferences":{"drugbank":["DB03882"],"chEBI":["18329"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3182543","canonicalSmiles":"COCCOCCOCCOCCOC","inchiKey":"ZUHZGEOKBKGPSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3182543","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144212464"],"drugbank":["DB14000"],"chEBI":["46785"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3188034","canonicalSmiles":"Cc1ccc(/C(=C\\CN2CCCC2)c2ccccn2)cc1.Cl.O","inchiKey":"CUZMOIXUFHOLLN-UMVVUDSKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIPROLIDINE HYDROCHLORIDE","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL855","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actidil","Myidyl","Pro-actidil","Triprolidine hydrochloride"],"synonyms":["Triprolidine hydrochloride"],"crossReferences":{"DailyMed":["triprolidine%20hydrochloride"],"PubChem":["144208046"],"chEBI":["32265"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1983."}
{"id":"CHEMBL319354","canonicalSmiles":"C[C@@H](O)[C@@H](N)C(=O)O","inchiKey":"AYFVYJQAPQTCCC-PWNYCUMCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-allothreonine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-allothreonine"],"crossReferences":{"drugbank":["DB03700"],"chEBI":["32826"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3218578","canonicalSmiles":"COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1","inchiKey":"BMMXYEBLEBULND-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BGT-226","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGT-226","NVP-BGT226"],"crossReferences":{"chEBI":["71967"]},"childChemblIds":["CHEMBL3545096"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["Orphanet_201","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL329522","canonicalSmiles":"O=C(c1cc(O)c(O)c(O)c1)c1ccc(O)c(O)c1O","inchiKey":"XEDWWPGWIXPVRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EXIFONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Hepatotoxicity"],"year":1989},"tradeNames":[],"synonyms":["Exifone"],"crossReferences":{"PubChem":["144208648","144213864","170466234"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1989 due to Hepatotoxicity."}
{"id":"CHEMBL3302622","canonicalSmiles":"CCC(=O)N(c1ccccc1)C1CCN(CC(O)c2ccccc2)CC1","inchiKey":"JEFVHLMGRUJLET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3302622","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01453"]},"childChemblIds":["CHEMBL3188286"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3325957","canonicalSmiles":"CN(C)[C@]1(c2ccccc2)CC[C@]2(CC1)OCCc1c3cc(F)ccc3[nH]c12.O=C(O)CC(O)(CC(=O)O)C(=O)O","inchiKey":"STODTOIHYHWPGO-FBGQUBCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3325957","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2364605","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL335538","canonicalSmiles":"Nc1ncnc2c1ncn2[C@H]1C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1","inchiKey":"SUYVUBYJARFZHO-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-Deoxyadenosine 5'-Triphosphate","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxyadenosine 5'-Triphosphate","Deoxyadenosine 5'-Triphosphate","dATP"],"crossReferences":{"Wikipedia":["Deoxyadenosine_triphosphate"],"drugbank":["DB03222"],"chEBI":["16284"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3392049","canonicalSmiles":"[O-]n1ccccc1=S.[O-]n1ccccc1=S.[Zn+2]","inchiKey":"PICXIOQBANWBIZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PYRITHIONE ZINC","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1650619","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Head & shoulders conditioner","Revlon zp11"],"synonyms":["Pyrithione zinc"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL349803","canonicalSmiles":"NS(=O)(=O)c1cc(C(=O)O)cc(N2CCCC2)c1Oc1ccccc1","inchiKey":"UJEWTUDSLQGTOA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRETANIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arelix","Arlix"],"synonyms":["HOE 118","Piretanide","S 73 4118"],"crossReferences":{"PubChem":["11112792","144204212","170465869","56463166"],"drugbank":["DB02925"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL350221","canonicalSmiles":"N[C@@H](Cc1c[nH]c2ccc(O)cc12)C(=O)O","inchiKey":"LDCYZAJDBXYCGN-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXITRIPTAN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Levotonine"],"synonyms":["5-hydroxy-l-tryptophan","5-hydroxytryptophan","5-hydroxytryptophan l-form","Oxitriptan"],"crossReferences":{"PubChem":["11111290","124890389","144204624","144208230","170466308","17388954","26752894","50105515","50105516","56463305","90340691"],"Wikipedia":["5-Hydroxytryptophan"],"drugbank":["DB02959"],"chEBI":["17780"]},"count":2,"approvedIndications":["EFO_0003761"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for unipolar depression and has 1 investigational indication."}
{"id":"CHEMBL350719","canonicalSmiles":"CCC(=O)C(C[C@H](C)N(C)C)(c1ccccc1)c1ccccc1","inchiKey":"USSIQXCVUWKGNF-KRWDZBQOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXTROMETHADONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Methadone","Dextromethadone","REL-1017","Rel-1017"],"crossReferences":{"drugbank":["DB15198"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3527085","canonicalSmiles":"CCN(CC)[14C](=O)C1(c2ccccc2)CC1CN.Cl","inchiKey":"XNCDYJFPRPDERF-ZEVXLFMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3527085","maximumClinicalTrialPhase":0,"parentId":"CHEMBL259209","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3544922","drugType":"Antibody","blackBoxWarning":false,"name":"OPICINUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-LINGO","BIIB-033","BIIB033","Opicinumab"],"count":3,"linkedTargets":{"rows":["ENSG00000169783"],"count":1},"linkedDiseases":{"rows":["EFO_0003885","EFO_0007405","EFO_0003929"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545112","drugType":"Small molecule","blackBoxWarning":false,"name":"ME-401","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Me-401"],"count":5,"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0000096","EFO_0000095","EFO_0000403","MONDO_0018906","EFO_1001469"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3545223","drugType":"Small molecule","blackBoxWarning":false,"name":"GW493838","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW-493838 X","GW-493838X","GW493838","Gw493838"],"count":1,"linkedTargets":{"rows":["ENSG00000163485"],"count":1},"linkedDiseases":{"rows":["EFO_0005762"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545252","canonicalSmiles":"CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O","inchiKey":"XCDIRYDKECHIPE-QHEQPUDQSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DOCETAXEL","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL92","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Docefrez","Docetaxel","Taxceus","Taxotere"],"synonyms":["Bind 014","CKD-810","Docetaxel","Docetaxel anhydrous","Docetaxel hydrate","Docetaxel trihydrate","NSC-628503","RP 56976","RP-56976","XRP6976"],"crossReferences":{"DailyMed":["docetaxel"],"chEBI":["59809"]},"count":108,"approvedIndications":["EFO_0000616","EFO_0003869","MONDO_0007254","EFO_0000305","EFO_0003060","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000137285","ENSG00000196230","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0003891","EFO_0000637","EFO_0003859","EFO_0004228","EFO_0000756","EFO_0000681","EFO_1000984","EFO_1001951","MONDO_0021310","EFO_0000178","EFO_0000564","MONDO_0002974","MONDO_0008903","MONDO_0001528","EFO_0008528","MONDO_0002038","EFO_0000198","EFO_0002618","EFO_1001931","EFO_0005922","EFO_0006911","HP_0002039","EFO_1001968","MONDO_0008315","EFO_0001663","Orphanet_398934","MONDO_0002691","MONDO_0018201","EFO_1000527","EFO_0004284","EFO_0000574","EFO_0001378","EFO_0001376","EFO_1000412","EFO_0000292","EFO_0005577","MONDO_0021117","MONDO_0007254","EFO_0004252","MONDO_0020654","EFO_0003817","MONDO_0001056","MONDO_0002158","EFO_1001974","EFO_0000196","EFO_0000707","EFO_0000616","EFO_0003897","EFO_0005088","EFO_0006859","EFO_1000601","EFO_0002916","Orphanet_44890","MONDO_0007576","EFO_0000304","MONDO_0002120","MONDO_0011962","EFO_0000702","EFO_0000199","MONDO_0002367","MONDO_0024880","EFO_0005232","MONDO_0003060","EFO_0003869","EFO_0001075","EFO_0004281","EFO_0000571","MONDO_0004222","EFO_0000228","MONDO_0003212","EFO_0000565","MONDO_0002352","MONDO_0002358","EFO_0000182","MONDO_0003199","HP_0012378","EFO_0001416","EFO_1000595","Orphanet_145","EFO_0003893","EFO_0000466","MONDO_0008170","EFO_0005842","EFO_0007355","EFO_0009708","MONDO_0044787","EFO_1001100","EFO_0005537","HP_0004326","EFO_0002428","EFO_0000233","EFO_0000432","EFO_0006544","EFO_1000613","MONDO_0021355","EFO_0003785","EFO_1000172","EFO_0002938","MONDO_0004192","EFO_0003866","EFO_0004230","EFO_0000708","MONDO_0021063","MONDO_0002087","MONDO_0024879","EFO_0000305","EFO_1000357","MONDO_0001187","EFO_0007362","EFO_1001480","EFO_1000044","EFO_1000043","MONDO_0001475","EFO_0003860","EFO_0006352","EFO_0000673","EFO_1001963","EFO_0002617","EFO_0002914","MONDO_0001402","EFO_0000503","EFO_0000313","EFO_0003060","EFO_1001214","EFO_0000311","EFO_0003863","EFO_0005570","EFO_0003865","EFO_0010282","EFO_0006861","MONDO_0003219","MONDO_0001325","EFO_0000691","EFO_0000181"],"count":134},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 approved and 102 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3545277","drugType":"Small molecule","blackBoxWarning":false,"name":"OMS405","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oms405"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL358722","canonicalSmiles":"O=C(O)C1CSCN1","inchiKey":"DZLNHFMRPBPULJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIMONACIC","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Timonacic"],"crossReferences":{"drugbank":["DB12856"],"chEBI":["64564"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707277","drugType":"Antibody","blackBoxWarning":false,"name":"DEPATUXIZUMAB MAFODOTIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-414","Abt-414","Depatuxizumab mafodotin"],"count":3,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001465","EFO_0000519"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3786343","canonicalSmiles":"C=CC(=O)Nc1cccc(Oc2nc(Nc3ccc(N4CCN(C)CC4)cc3)nc3ccsc23)c1","inchiKey":"FDMQDKQUTRLUBU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLMUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 1482694","BI-1482694","HM-61713","HM61713","Hm-61713","Olmutinib"],"crossReferences":{"drugbank":["DB13164"]},"childChemblIds":["CHEMBL3989930"],"count":2,"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003060"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3833344","drugType":"Antibody","blackBoxWarning":false,"name":"GANCOTAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gancotamab","MM-302","Mm-302"],"count":1,"linkedTargets":{"rows":["ENSG00000131747","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3833379","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLD SODIUM THIOSULFATE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3990248","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gold sodium thiosulfate","Sodium aurotiosulfate"],"crossReferences":{"DrugCentral":["4707"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL387347","canonicalSmiles":"O=C(CCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1cc(O)c(O)c([N+](=O)[O-])c1","inchiKey":"KVIVJQWOYSWCCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL387347","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03336"]},"childChemblIds":["CHEMBL535825"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3909070","canonicalSmiles":"Cl.Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1","inchiKey":"GDGYRKDHQORLNT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3909070","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3545076","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL395347","canonicalSmiles":"O=C(O)COc1cc(F)ccc1C(=S)NCc1ccc(Br)cc1F","inchiKey":"JCZUIWYXULSXSW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL395347","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08084"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3976339","canonicalSmiles":"COc1cccc(C2(O)CC(O)CCC2CN(C)C)c1.Cl","inchiKey":"BCTAUJYAQUAGMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3976339","maximumClinicalTrialPhase":0,"parentId":"CHEMBL3989680","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3976780","canonicalSmiles":"O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"CDAISMWEOUEBRE-SHFUYGGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3976780","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15350"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989520","canonicalSmiles":"NCCc1c[nH]cn1.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"ZHIBQGJKHVBLJJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"HISTAMINE PHOSPHATE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL90","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Histamine phosphate"],"synonyms":["Histamine phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989525","canonicalSmiles":"[N-]=[N+]=NCC(=O)N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1","inchiKey":"SGRUZFCHLOFYHZ-MWLCHTKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZIDAMFENICOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azidamfenicol","Azidoamphenicol"],"crossReferences":{"drugbank":["DB13294"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989777","canonicalSmiles":"Cl.Cl.NCCNCCNCCN","inchiKey":"WYHIICXRPHEJKI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIENTINE HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL609","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Metalite","Syprine"],"synonyms":["MK-0681","Trientine dihydrochloride","Trientine hydrochloride"],"crossReferences":{"DailyMed":["trientine%20hydrochloride"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL3990017","drugType":"Enzyme","blackBoxWarning":false,"name":"LESINIDASE ALFA","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lesinidase alfa","SBC-103"],"count":1,"description":"Enzyme drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL399598","canonicalSmiles":"O=C(O)COc1cc(F)ccc1C(=O)NCc1nc2c(F)c(F)cc(F)c2s1","inchiKey":"ZCAGEXZTORJQDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL399598","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02834"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL405130","canonicalSmiles":"COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC","inchiKey":"HOZUXBLMYUPGPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WHI-P131","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["WHI-P131","Whi-p131"],"childChemblIds":["CHEMBL555201"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4061772","canonicalSmiles":"O=S(=O)(O)O.S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1","inchiKey":"JWJVCSIWNKDPOM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4061772","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2103851","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4078100","canonicalSmiles":"COc1nnc2ccc(N3CCC(c4ccc(OCCN5CCN(C)C(=O)[C@H]5C)cc4)CC3)nn12","inchiKey":"RSMYFSPOTCDHHJ-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-5153","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-5153","AZD5153","Azd 5153","Azd-5153","Azd5153"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL408867","canonicalSmiles":"COc1ccc(CCN2CCN(CCCc3ccccc3)CC2)cc1OC","inchiKey":"UVSWWUWQVAQPJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"[11C]SA4503","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137275970"],"drugbank":["DB06618"]},"childChemblIds":["CHEMBL3216524","CHEMBL2311153"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL411907","canonicalSmiles":"C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C","inchiKey":"QIUASFSNWYMDFS-NILGECQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SONOLISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PX-866","Px-866","Sonolisib"],"crossReferences":{"drugbank":["DB12601"],"chEBI":["65345"]},"count":4,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0008315","EFO_0000519","EFO_0000311"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL41306","canonicalSmiles":"CSc1cccc(N(C)C(=N)Nc2cc(SC)ccc2Cl)c1","inchiKey":"JHVHEDNLONERHY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CNS-5161","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cns-5161"],"crossReferences":{"drugbank":["DB05824"]},"childChemblIds":["CHEMBL1079972"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4173394","canonicalSmiles":"CCOc1ccc(Nc2ccc(/C(=C3/C=C/C(=[N+](/CC)Cc4cccc(S(=O)(=O)[O-])c4)C=C3C)c3ccc(N(CC)Cc4cccc(S(=O)(=O)[O-])c4)cc3C)cc2)cc1.[Na+]","inchiKey":"RWVGQQGBQSJDQV-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"BRILLIANT BLUE G","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL4301898","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tissueblue"],"synonyms":["Brilliant blue g"],"crossReferences":{"DailyMed":["brilliant%20blue%20g"],"drugbank":["DB15594"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2019."}
{"id":"CHEMBL4297302","canonicalSmiles":"CCS(=O)(=O)c1ccc(Oc2cc(O[C@@H](C)CO)cc(C(=O)Nc3ccn(C)n3)c2)cn1.CS(=O)(=O)O","inchiKey":"PIDNRTWDGDJKSQ-UQKRIMTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0941","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3580737","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK0941","Mk-0941","Mk0941"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297461","canonicalSmiles":"COc1cccc2[nH]c3c4c(c5c(c3c12)C(=O)N(CN1CCN(C)CC1)C5=O)CCC4","inchiKey":"CTLOSZHDGZLOQE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEP-9722","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP-9722","Cep 9722","Cep-9722"],"crossReferences":{"drugbank":["DB14882"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297521","canonicalSmiles":"COCc1nn2c(CN3C[C@@H](CC(F)(F)Cl)CC3=O)c(C(F)(F)F)nc2s1","inchiKey":"DCXFIOLWWRXEQH-SSDOTTSWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PADSEVONIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Padsevonil","UCB-0942","UCB0942","UCB1415943-000"],"crossReferences":{"drugbank":["DB14977"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297652","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTIMONY","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Antimony","C.I. 77050"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297666","canonicalSmiles":"CC(C)OC(=O)CNc1cccc(CN(Cc2ccc(-n3cccn3)cc2)S(=O)(=O)c2cccnc2)n1","inchiKey":"VIQCWEGEHRBLAC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMIDENEPAG ISOPROPYL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DE-117","De-117","Omidenepag isopropyl"],"crossReferences":{"drugbank":["DB15071"]},"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297713","drugType":"Antibody","blackBoxWarning":false,"name":"CABIRALIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cabiralizumab","Fpa008"],"count":6,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4297726","drugType":"Unknown","blackBoxWarning":false,"name":"CHO-H01","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHO-H01","Cho-h01"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297731","drugType":"Unknown","blackBoxWarning":false,"name":"COPPER HISTIDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Copper histidine","J1.412.545K"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297732","drugType":"Antibody","blackBoxWarning":false,"name":"ZILTIVEKIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["COR-001","COR001","Cor-001","Ziltivekimab"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297984","drugType":"Antibody","blackBoxWarning":false,"name":"NAXITAMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hu3F8","Hu3f8","Naxitamab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4298156","canonicalSmiles":"COCCNCCc1cccc(Nc2ncc3c(n2)-c2ccccc2[C@H](c2ccccc2F)C3)c1.Cl.Cl","inchiKey":"OLDWOVJAXRWCGT-FBHGDYMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DERAZANTINIB HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL4297187","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AQ14741087","ARQ 087.2HCl","Derazantinib hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL432234","canonicalSmiles":"O=C(O)c1ccc(-c2cc(F)cc(F)c2)cc1","inchiKey":"VCEFNMHMLWBFNV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL432234","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07753"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL434200","canonicalSmiles":"CC(C)(C)NCC(O)COc1cccc2c1SCCC2","inchiKey":"HTWFXPCUFWKXOP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TERTATOLOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artex"],"synonyms":["S-2395","Tertatolol"],"crossReferences":{"Wikipedia":["Tertatolol"],"drugbank":["DB13775"]},"count":1,"approvedIndications":["EFO_0000319"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL4594357","drugType":"Antibody","blackBoxWarning":false,"name":"IANALUMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ianalumab"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594423","canonicalSmiles":"CN1CC[C@H](c2c(OP(=O)(O)O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1","inchiKey":"YRNFLVUMZIRYKY-BLLLJJGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TP-1287","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TP-1287","Tp-1287"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594428","canonicalSmiles":"COc1cc(OC)c(F)c(COc2cnc(Nc3cnn(CCO)c3)nc2)c1F","inchiKey":"VDZZYOJYLLNBTD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASP-5878","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ASP-5878","ASP5878","Asp 5878","Asp-5878","Asp5878"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594449","canonicalSmiles":"C#CCN(c1ccc(C(=O)N[C@@H](CCC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)cc1)[C@H]1CCc2cc3nc(CO)[nH]c(=O)c3cc21","inchiKey":"NVHRBQOZEMFKLD-CUYJMHBOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDETREXED","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["6S-BGC-945","BGC-945","CB-300945 (S)","Idetrexed","ONX-0801","Onx-0801"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594457","drugType":"Unknown","blackBoxWarning":false,"name":"AL-78898A","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-78898A","Al-78898a","POT-4","Pot-4"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL461805","canonicalSmiles":"CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\\Nc1cccc(-c2cccc(C(=O)[O-])c2)c1O.[Na+]","inchiKey":"NOCDTUJZPNKWLU-OUFJFOJPSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL461805","maximumClinicalTrialPhase":0,"parentId":"CHEMBL461101","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL462547","canonicalSmiles":"CCOC(N)=O","inchiKey":"JOYRKODLDBILNP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URETHANE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Ethyl carbamate","Urethan","Urethane"],"crossReferences":{"PubChem":["144204951","144208959","144210812","170466651","26748777"],"Wikipedia":["Ethyl_carbamate"],"drugbank":["DB04827"],"chEBI":["17967"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL478120","canonicalSmiles":"CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn4c3c2OCN4C)CC1","inchiKey":"BPFYOAJNDMUVBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MARBOFLOXACIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Marbofloxacin"],"crossReferences":{"PubChem":["144205959","170465732","174006196","26660734","29218068"],"Wikipedia":["Marbofloxacin"],"drugbank":["DB11426"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489586","canonicalSmiles":"N#Cc1cc(Cl)cc(Oc2cc(OCc3n[nH]c4nc(N)ccc34)ccc2Cl)c1","inchiKey":"KXDIHAQCVNNLIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-4965","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-4965"],"crossReferences":{"drugbank":["DB08460"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL498485","canonicalSmiles":"COc1ccc(-c2oc3c(CC=C(C)C)c(O)cc(O)c3c(=O)c2O)cc1","inchiKey":"TUUXBSASAQJECY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICARITIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Icaritin","SGN-162","SGN162"],"crossReferences":{"drugbank":["DB12672"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL52885","canonicalSmiles":"Cn1cc(C2=C(c3cn(C)c4cc([N+](=O)[O-])ccc34)C(=O)NC2=O)c2ccccc21","inchiKey":"OVSKGTONMLKNPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ENMD-981693","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ENMD 981693","ENMD-2076","ENMD-981693","Enmd-981693","MKC-1","R-440","Ro-317453"],"crossReferences":{"drugbank":["DB05608"]},"count":6,"linkedTargets":{"rows":["ENSG00000087586","ENSG00000128052","ENSG00000066468","ENSG00000068078","ENSG00000113721","ENSG00000010810","ENSG00000134853","ENSG00000101336","ENSG00000000938","ENSG00000182866","ENSG00000077782","ENSG00000160867","ENSG00000254087","ENSG00000125508","ENSG00000136573","ENSG00000111816","ENSG00000176105","ENSG00000122025","ENSG00000197122"],"count":19},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","MONDO_0007254","EFO_0003060","EFO_0000311","EFO_1001951"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL536932","canonicalSmiles":"Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1.Cl","inchiKey":"GHKABPDNWHXLHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINAPRINE HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL278819","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["56422435","855930"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL538973","canonicalSmiles":"CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1.Cl","inchiKey":"ARWPDHKDEREYEE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOZAPINE CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL42","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Clozapine"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL553532","canonicalSmiles":"Cl.O=C1NC(=O)C(c2ccccc2)(c2ccccc2)N1","inchiKey":"WWVSRSBVTDLJAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYTOIN CHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL16","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL557217","canonicalSmiles":"CC(C)C[C@@H](NC(=O)CNC(=O)[C@@H](NC=O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCCO)C(C)C)C(C)C)C(C)C","inchiKey":"NDAYQJDHGXTBJL-MWWSRJDJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GRAMICIDIN D","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gramicidin D"],"crossReferences":{"Wikipedia":["Gramicidin"],"drugbank":["DB00027"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL572528","canonicalSmiles":"Nc1c(S(=O)(=O)O)cc(Nc2ccc(Nc3nc(Cl)nc(Nc4ccccc4S(=O)(=O)O)n3)c(S(=O)(=O)O)c2)c2c1C(=O)c1ccccc1C2=O","inchiKey":"YKCWQPZFAFZLBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CIBACRON BLUE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cibacron Blue 3Ga"],"crossReferences":{"drugbank":["DB02633"]},"childChemblIds":["CHEMBL134193"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL61780","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C(C)C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO","inchiKey":"TUYWTLTWNJOZNY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TEZOSENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Veletri"],"synonyms":["ACT-050089","Ro 61-0612","Ro-610612","Tezosentan"],"crossReferences":{"Wikipedia":["Tezosentan"],"drugbank":["DB06558"]},"count":2,"linkedTargets":{"rows":["ENSG00000151617","ENSG00000136160"],"count":2},"linkedDiseases":{"rows":["EFO_0001361","EFO_0003144"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL655","canonicalSmiles":"Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2","inchiKey":"DDLIGBOFAVUZHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MIDAZOLAM","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nayzilam"],"synonyms":["Midazolam","Midazolam civ","USL-261","USL261"],"crossReferences":{"DailyMed":["midazolam","midazolam%20hydrochloride"],"PubChem":["50113067"],"Wikipedia":["Midazolam"],"drugbank":["DB00683"],"chEBI":["6931"]},"childChemblIds":["CHEMBL2106922","CHEMBL1200420"],"count":87,"approvedIndications":["EFO_0000474"],"linkedTargets":{"rows":["ENSG00000182256","ENSG00000022355","ENSG00000011677","ENSG00000113327","ENSG00000151834","ENSG00000163285","ENSG00000186297"],"count":7},"linkedDiseases":{"rows":["EFO_0002610","EFO_0000249","EFO_0003768","EFO_0005952","EFO_0003914","HP_0100543","EFO_0003931","EFO_0000588","EFO_0009513","EFO_0003819","MONDO_0008903","EFO_0007157","EFO_0000676","EFO_0009686","HP_0012532","HP_0012076","HP_0001623","EFO_0006911","EFO_0005323","EFO_0000662","EFO_0000384","MONDO_0008315","EFO_0000546","EFO_0001422","MP_0001914","EFO_0005741","EFO_1000049","HP_0001336","EFO_0007328","EFO_0007634","EFO_0001378","EFO_0003767","EFO_0004320","HP_0000726","MONDO_0007254","EFO_1001413","EFO_1000637","EFO_0000289","MONDO_0002050","EFO_0009854","EFO_0000616","EFO_0005774","MONDO_0021204","EFO_0003832","EFO_0001645","HP_0011110","EFO_0000222","EFO_0003929","EFO_0001358","EFO_0000618","HP_0001250","EFO_0000319","EFO_0001073","EFO_0003843","EFO_0000537","HP_0000713","EFO_0004220","EFO_0000764","MONDO_0043510","MONDO_0024880","EFO_0005411","EFO_0008525","EFO_0000729","EFO_0003869","HP_0000989","MONDO_0002009","HP_0012735","EFO_1001328","EFO_0003015","HP_0001298","EFO_0000540","EFO_0003829","HP_0100790","EFO_0002506","EFO_0000544","EFO_1001134","HP_0003419","EFO_0000253","HP_0012378","EFO_0000692","EFO_0007623","EFO_0001074","EFO_0002508","EFO_0000701","Orphanet_3389","EFO_0004239","HP_0100806","HP_0002045","HP_0030833","EFO_0004888","EFO_0001360","EFO_0005251","EFO_0009878","EFO_0001059","EFO_1001494","EFO_0006834","EFO_0001065","EFO_1001905","EFO_1001454","EFO_1001249","EFO_0000274","EFO_0009267","Orphanet_68380","HP_0000083","EFO_0000474","EFO_0003144","EFO_0000673","EFO_0004272","EFO_0003047","EFO_0004242","EFO_0005230","EFO_0002617","EFO_0000685","HP_0002140","EFO_0000545","EFO_1001884","EFO_0003060","EFO_0000311","EFO_0003863","EFO_0003890","EFO_0000713","EFO_0000095","EFO_0003854"],"count":123},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for epilepsy and has 86 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL7463","canonicalSmiles":"CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21","inchiKey":"QMGUOJYZJKLOLH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GF-109203","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GF-109203","GF-109203X"],"crossReferences":{"PubChem":["11113674","26751859","26751860"],"drugbank":["DB03777"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL77","canonicalSmiles":"C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1C32OO4","inchiKey":"BLUAFEHZUWYNDE-XRNKLDBLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARTEMISIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-hydroxysantonin","Artemisin","GNF-Pf-5341"],"crossReferences":{"PubChem":["50109945"],"Wikipedia":["Artemisinin"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL787","canonicalSmiles":"CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1","inchiKey":"UCHDWCPVSPXUMX-TZIWLTJVSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MONTELUKAST","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Singulair"],"synonyms":["MK-476","Montelukast"],"crossReferences":{"DailyMed":["montelukast%20sodium"],"Wikipedia":["Montelukast"],"drugbank":["DB00471"],"chEBI":["50730"]},"childChemblIds":["CHEMBL1200681"],"count":22,"approvedIndications":["EFO_0005854","HP_0006536","EFO_0000270","EFO_0003956"],"linkedTargets":{"rows":["ENSG00000173198"],"count":1},"linkedDiseases":{"rows":["Orphanet_64739","EFO_0003095","HP_0012735","EFO_0007183","Orphanet_232","EFO_0000249","EFO_0010638","EFO_0000274","EFO_0000540","EFO_0009715","HP_0011950","EFO_0009836","Orphanet_70589","HP_0040187","EFO_0000544","EFO_0003917","EFO_1001417","EFO_0003877","EFO_0005854","EFO_0000616","EFO_0000685","EFO_0008521","EFO_0000220","EFO_0008590","EFO_0009661","EFO_0000222","MONDO_0002465","EFO_0003843","EFO_0004232","EFO_0003885","HP_0006536","MONDO_0100096","EFO_0000684","EFO_0000270","EFO_0000764","EFO_0000649","EFO_0001378","EFO_0000341","EFO_0004227","HP_0025428","EFO_0003918","EFO_0005672","EFO_0003956"],"count":43},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and has 4 approved and 18 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL821","canonicalSmiles":"N=C(N)N","inchiKey":"ZRALSGWEFCBTJO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANIDINE","yearOfFirstApproval":1939,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Guanidine"],"crossReferences":{"DailyMed":["guanidine%20hydrochloride"],"Wikipedia":["Guanidine"],"drugbank":["DB00536"],"chEBI":["42820"]},"childChemblIds":["CHEMBL1200728","CHEMBL3187576"],"count":1,"linkedTargets":{"rows":["ENSG00000164794","ENSG00000116396","ENSG00000184408","ENSG00000162975","ENSG00000171126","ENSG00000177272","ENSG00000053918","ENSG00000168263","ENSG00000129159","ENSG00000140015","ENSG00000026559","ENSG00000143105","ENSG00000182674","ENSG00000173826","ENSG00000184156","ENSG00000185760","ENSG00000124134","ENSG00000183960","ENSG00000111262","ENSG00000102057","ENSG00000178342","ENSG00000055118","ENSG00000117013","ENSG00000170745","ENSG00000130037","ENSG00000131398","ENSG00000182255","ENSG00000075043","ENSG00000143473","ENSG00000168418","ENSG00000158445","ENSG00000177301","ENSG00000089558","ENSG00000135519","ENSG00000151079","ENSG00000166006","ENSG00000104848","ENSG00000156486","ENSG00000171385","ENSG00000184611"],"count":40},"linkedDiseases":{"rows":["EFO_1001901","EFO_0009708"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1939 and has 1 investigational indication."}
{"id":"CHEMBL828","canonicalSmiles":"c1ccc2c(c1)Nc1ccccc1S2","inchiKey":"WJFKNYWRSNBZNX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOTHIAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nemazine"],"synonyms":["Phenothiazine","Phenthiazine","Thiodiphenylamine"],"crossReferences":{"PubChem":["11532870","144204641","144213971","170466563","17389765","26752918","56436655","57287888","92093121"],"Wikipedia":["Phenothiazine"],"drugbank":["DB11447"],"chEBI":["37931"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL84844","canonicalSmiles":"OC[C@H]1NC[C@@H](O)[C@@H](O)[C@@H]1O","inchiKey":"LXBIFEVIBLOUGU-KVTDHHQDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYMANNOJIRIMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Deoxymannojirimycin"],"crossReferences":{"PubChem":["26752141"],"drugbank":["DB03955"]},"childChemblIds":["CHEMBL4303328"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL91397","canonicalSmiles":"Cc1cncc(CN2CCC(=C3c4ccc(Cl)cc4CCc4cccnc43)CC2)c1","inchiKey":"WUZYKBABMWJHDL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUPATADINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rupatadine","UR-12592"],"crossReferences":{"Wikipedia":["Rupatadine"],"drugbank":["DB11614"]},"count":4,"linkedTargets":{"rows":["ENSG00000169403","ENSG00000196639"],"count":2},"linkedDiseases":{"rows":["EFO_0005854","EFO_0000685","EFO_0005531","EFO_0009001","EFO_1001881","EFO_0003785"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL916","canonicalSmiles":"CCCCS(=O)(=O)N[C@@H](Cc1ccc(OCCCCC2CCNCC2)cc1)C(=O)O","inchiKey":"COKMIXFXJJXBQG-NRFANRHFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TIROFIBAN","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Aggrastat","L-700462","MK-383","Tirofiban"],"crossReferences":{"DailyMed":["tirofiban%20hydrochloride"],"Wikipedia":["Tirofiban"],"drugbank":["DB00775"],"chEBI":["9605"]},"childChemblIds":["CHEMBL3189072","CHEMBL1704"],"count":7,"approvedIndications":["HP_0004419"],"linkedTargets":{"rows":["ENSG00000259207","ENSG00000005961"],"count":2},"linkedDiseases":{"rows":["EFO_0009686","HP_0002140","EFO_0001645","EFO_0004286","HP_0000083","MONDO_0100096","EFO_0008585","EFO_0000712","EFO_0008583","EFO_0000612","EFO_0007541","HP_0004419","EFO_0005672","EFO_0008586"],"count":14},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for recurrent thrombophlebitis and has 6 investigational indications."}
{"id":"CHEMBL944","canonicalSmiles":"CCN(CC)CCOC(=O)c1ccc(N)cc1Cl.Cl","inchiKey":"SZKQYDBPUCZLRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROPROCAINE HYDROCHLORIDE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1179047","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ampres","Chloroprocaine hydrochloride","Clorotekal","Nesacaine","Nesacaine-mpf"],"synonyms":["Chloroprocaine HCl","Chloroprocaine hydrochloride","Chlorprocaine chloride"],"crossReferences":{"DailyMed":["chloroprocaine%20hydrochloride"],"PubChem":["144206478"],"chEBI":["3637"]},"count":1,"linkedTargets":{"rows":["ENSG00000196876","ENSG00000185313","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1955 and has 1 investigational indication."}
